about
A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritisInhibitor of DNA binding 1 as a secreted angiogenic transcription factor in rheumatoid arthritisIL-17 contributes to angiogenesis in rheumatoid arthritis.Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis.Inhibition of adjuvant-induced arthritis by nasal administration of novel synthetic peptides from heat shock protein 65.Characterization of CCL19 and CCL21 in rheumatoid arthritis.Vascular endothelial growth factor A (VEGFA) polymorphisms in Chinese patients with rheumatoid arthritis.Local expression of interleukin-27 ameliorates collagen-induced arthritisUncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation.Serum Angiogenesis Markers and Their Correlation with Ultrasound-Detected Synovitis in Juvenile Idiopathic Arthritis.A polymorphism in the interleukin-4 receptor affects the ability of interleukin-4 to regulate Th17 cells: a possible immunoregulatory mechanism for genetic control of the severity of rheumatoid arthritisThe gene expression profile of preclinical autoimmune arthritis and its modulation by a tolerogenic disease-protective antigenic challengeRole of the CCL21 and CCR7 pathways in rheumatoid arthritis angiogenesis.c-Jun N-Terminal Kinase in Inflammation and Rheumatic Diseases.Changes in focal adhesion kinase expression in rats with collagen-induced arthritis and efficacy of intervention with disease modifying anti-rheumatic drugs alone or in combinationRole of TH-17 cells in rheumatic and other autoimmune diseasesSerum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis.Phospholipase D1 has a pivotal role in interleukin-1β-driven chronic autoimmune arthritis through regulation of NF-κB, hypoxia-inducible factor 1α, and FoxO3aAngiogenesis in rheumatoid arthritis is fostered directly by toll-like receptor 5 ligation and indirectly through interleukin-17 induction.Platelet-associated angiogenesis regulating factors: a pharmacological perspective.Putative effects of potentially anti-angiogenic drugs in rheumatic diseases.Temporal cytokine expression and the target organ attributes unravel novel aspects of autoimmune arthritis.The potential role of angiogenic factors in rheumatoid arthritis.TLRs, future potential therapeutic targets for RA.Inhibition of Angiogenesis: A Novel Effect of Zataria Multiflora.Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles.Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.Boron neutron capture synovectomy (BNCS) as a potential therapy for rheumatoid arthritis: radiobiological studies at RA-1 Nuclear Reactor in a model of antigen-induced arthritis in rabbits.Boron neutron capture synovectomy (BNCS) as a potential therapy for rheumatoid arthritis: boron biodistribution study in a model of antigen-induced arthritis in rabbits.Synovitis in mice with inflammatory arthritis monitored with quantitative analysis of dynamic contrast-enhanced NIR fluorescence imaging using iRGD-targeted liposomes as fluorescence probes.The Micro-RNA Expression Profiles of Autoimmune Arthritis Reveal Novel Biomarkers of the Disease and Therapeutic Response
P2860
Q26823326-8671AA7E-8909-48F5-987B-E43FB0A0BC04Q33766726-BCF0DB98-5924-41AE-99D3-1E2F2604EF4AQ33802908-B3D5E1E7-AE1F-4975-B9BF-0327133EA84DQ33964836-9A0492CF-DA10-4BD2-BBC0-CE83BE44583CQ33970282-4FEE8DE9-E822-448D-8CEF-DF580A03287AQ34814351-29872D7A-5217-45B9-88CB-ACE903703CEAQ34814596-BA440D5B-719D-4B09-8A00-8F8EB489E6A4Q35046582-97E94B48-D45B-4B87-AF2B-3D39A3C1DB53Q35227259-91EA71C8-A0FF-4B26-B3F8-CB15A8A2ECB3Q35614273-DFD21E87-5026-40D6-BE90-8C23E4BBA5CEQ35620302-024E5CE9-C8C2-4A8B-8B0B-5E69F58A051CQ35840722-6FCBD243-97C6-4E84-BD02-3F5A0463F8C7Q36131157-89D4899E-B31A-498E-8A8B-978A12761D6CQ36286056-D9574B17-D8C8-49D6-9569-BCC65D3D486FQ36511660-28685266-A4B2-4CEA-85E8-BBB793DCD851Q36795816-14094EC9-6E7E-455B-9D2E-17C64636003BQ36830906-DB9A999B-A33E-46B0-9CFD-6EABAD7C9E83Q36978352-F9DE88DC-0F82-4027-B919-F5CEF103BA92Q37060590-7EEE296D-FA18-464B-81D2-E0FF8CC63C1DQ38003425-65292173-B046-4E99-A7B8-5A53305ABE94Q38160325-DDEAADBE-3A63-44A6-90E2-18ED90643309Q38179171-54D853F3-B1A6-430E-9161-B8CD42B88092Q38182175-095A0F1E-BE8F-4C8B-B197-C32366420E31Q38781354-A4FE6577-1025-4187-A24A-08BE7F3DBF50Q41553593-1916C255-CB66-4ADB-8B21-FCC7070F8E35Q41879624-14CAA16A-5C2C-4360-A225-AB93307F1A75Q44449871-F1895E0A-4266-49D0-A31A-7EF97E555C04Q48256058-2F0C954F-600E-47A4-B99D-C783F3B8631FQ51118091-BD3BE0A5-940B-4818-9E64-725C20EF2C9FQ52608824-7469EFFD-8E1A-4EB0-822B-BF8F3D7E4F99Q58799982-67BD9A2B-8896-424E-A3F9-D0AEE10DAC62
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Angiogenesis and its targeting in rheumatoid arthritis
@ast
Angiogenesis and its targeting in rheumatoid arthritis
@en
Angiogenesis and its targeting in rheumatoid arthritis
@nl
type
label
Angiogenesis and its targeting in rheumatoid arthritis
@ast
Angiogenesis and its targeting in rheumatoid arthritis
@en
Angiogenesis and its targeting in rheumatoid arthritis
@nl
prefLabel
Angiogenesis and its targeting in rheumatoid arthritis
@ast
Angiogenesis and its targeting in rheumatoid arthritis
@en
Angiogenesis and its targeting in rheumatoid arthritis
@nl
P2860
P1476
Angiogenesis and its targeting in rheumatoid arthritis
@en
P2093
Alisa E Koch
Zoltán Szekanecz
P2860
P356
10.1016/J.VPH.2009.02.002
P577
2009-02-13T00:00:00Z